Search Results
for psychedelic-assisted treatments currently. For example, a recent Phase III trial of MDMA-assisted treatment for post-traumatic stress disorder represents years of herculean work performed in multiple nations and reveals a promising effect size of
, which displayed positive results for MDMA assisted psychotherapy in the treatment of post-traumatic stress disorder. Also of importance, were three seminal papers displaying the use of psilocybin for the treatment of anxiety and depression in patients
far, not the only means. The psychostimulant 3,4-Methylenedioxymethamphetamine (MDMA) is a prototypical entactogen characterized by its ability to induce acute feelings of sociability ( Regan, Margolis, de Wit, & Lyubomirsky, 2021 ) and heightened
should consider that MDMA-assisted psychotherapy, the first P-AT likely to be federally approved, has been used to treat patients specifically with PTSD ( Mitchell et al., 2021 ). Because PTSD is a common outcome of sexual abuse ( Scott et al., 2017 ) and
can get that wonderful perfect balance of like a little bit trippy, a little bit energized, and MDMA making it really nice to be around the people, and making you feel connected and want to be in community. It's almost an art form to curate your own
effectiveness there is a need for the development of new treatments ( Cloitre, Stolbach, Herman, van der Kolk, Pynoose, Wang & Petkova, 2009 ). Pharmacologically assisted psychotherapy has been shown to be beneficial. MDMA
, Reed, and Aggarwal ( 2019 ) describe culturally informed research design and treatment issues, with respect to a 3,4-methylenedioxy-methamphetamine (MDMA)-assisted psychotherapy study for post-traumatic stress disorder (PTSD) at a university medical
, only two investigators for MDMA-assisted psychotherapy studies are women of color, Marcela Ot'alora, M.A., L.P.C. (Latina) and Monnica Williams, Ph.D. (Black) and trainees in psychedelic-assisted therapy programs remain overwhelmingly White. Notably, in
suggested to be beneficial in the treatment of substance-use disorders ( dos Santos et al., 2016 ; Krebs & Johansen, 2012 ). Similarly, 3,4,-methylenedioxymethamphetamine (MDMA) has been shown to be efficacious as an adjunct to psychotherapy in the
more clinical studies are needed. Psychedelic substances and non-classic psychedelic compounds, such as MDMA and ketamine, may possess empathogenic qualities, therefore it is possible that such agents could be useful in facilitating couples therapy
